Agimexpharm Pharmaceutical JSC (HSTC:AGP) Other Current Receivables: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:AGP Agimexpharm Pharmaceutical JSC HSTC:AGP
13 GF Score
Price ₫32,300.00
! 1 Warning Sign
View Full Analysis

What is Agimexpharm Pharmaceutical JSC Other Current Receivables?

Agimexpharm Pharmaceutical JSC HSTC:AGP +4.19% 13 Other Current Receivables is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:AGP with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Agimexpharm Pharmaceutical JSC's Other Current Receivables for the quarter that ended in . 20 was ₫0.00 Mil.

Agimexpharm Pharmaceutical JSC Other Current Receivables Related Terms

Agimexpharm Pharmaceutical JSC Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Agimexpharm Pharmaceutical JSC's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agimexpharm Pharmaceutical JSC Other Current Receivables Chart

Agimexpharm Pharmaceutical JSC Annual Data
Trend
Other Current Receivables

Agimexpharm Pharmaceutical JSC Semi-Annual Data
Other Current Receivables
HSTC:AGP
13GF Score
Agimexpharm Pharmaceutical JSC HSTC:AGP
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agimexpharm Pharmaceutical JSC Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₫0.00 Mil mean?
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a Other Current Receivables of ₫0.00 Mil as of . 20. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Agimexpharm Pharmaceutical JSC and its competitors.
Is Agimexpharm Pharmaceutical JSC's Other Current Receivables too high?
Agimexpharm Pharmaceutical JSC's current Other Current Receivables is ₫0.00 Mil. Overall, Agimexpharm Pharmaceutical JSC has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Agimexpharm Pharmaceutical JSC's Other Current Receivables compare to ?
Agimexpharm Pharmaceutical JSC's Other Current Receivables of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Agimexpharm Pharmaceutical JSC and its competitors. Agimexpharm Pharmaceutical JSC's current Other Current Receivables is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agimexpharm Pharmaceutical JSC stock overvalued right now?
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a current Other Current Receivables of ₫0.00 Mil. The current Other Current Receivables is ₫0.00 Mil. Agimexpharm Pharmaceutical JSC's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Agimexpharm Pharmaceutical JSC (HSTC:AGP), the current Other Current Receivables is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Agimexpharm Pharmaceutical JSC Business Description

Comparable Companies
Address 27 Nguyen Thai Hoc, My Binh Ward, An Giang Province, Long Xuyen, VNM
Agimexpharm Pharmaceutical JSC is engaged in producing and trading chemical pharmaceuticals and herbal medicines, health supplements, cosmetics, and medical equipment.
13GF Score

Get the complete analysis for HSTC:AGP

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫32,300.00
Price